Date: May 30, 2013
- Jerry Penso, MD, MBA, Chief Medical and Quality Officer, American Medical Group Association
- Phil Yphantides, MD, Hypertension and Diabetes Physician Champion, Sharp Rees-Stealy Medical Group
- Ola Akinboboye, MD, MPH, FACC, Associate Professor or Clinical Medicine, Weill Medical College of Cornell University; Medical Director, Queens Heart Institute; President, Association of Black Cardiologists
- Bob Mathews, President and CEO, MediSync
In order to improve health outcomes and slow health care spending in the US, much of which is fueled by millions of people with poorly managed chronic conditions, health care providers are rethinking how they engage with patients who are most at risk.
Hypertension is a case in point. Left untreated, individuals are on track to develop heart disease, strokes, and more. Yet the US Centers for Disease Control and Prevention (CDC) estimate that 30 million Americans with high blood pressure aren’t receiving the proper care. The reasons are complex and multifaceted. That’s why the American Medical Group Foundation decided six months ago to harvest the best hypertension interventions and innovations from leading medical group practices, and spread the learning via Measure Up, Pressure Down
, a three-year national campaign. This WIHI looks at how the initiative is progressing.
Each guest has a unique perspective on the issues surrounding hypertension, as well as experience transforming group practices to deliver the right care to the right patient at the right time. Our guests agree that access to primary care is an important factor in untreated high blood pressure, but they assert that this tends to obscure other defects in the system. That’s why the campaign planks, described in a detailed toolkit
, focus on eliminating “dropped balls” and map out ways medical groups can more reliably and accurately engage with the patients with high blood pressure they do see.
Learn about an effort that promises to impact both health care delivery and population health.